View drug registration information details.


ItemsRegistration information
ID1702
No1702
Brand NameLUCICAPIVA
IngredientsCAPAVASERTIB 200 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 64'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsIN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR POSITIVE, HYMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER WITH ONE OR MORE PIK3CA/AKT1/PTEN ALTERATION FOLLOWING PROGRESSION ON AT LEAST ONE ENDOCRINE BASED REGIMENT ON THE METASTATIC SETTING OR RECURRENT ON OR WITHIN 12 MONTHS OF CONPLETING ADJUVANT THERAPY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionYELLOW, BICONVEX FILM COATED TABLET, WITH LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 L 1160/24
FDD Registration Date21-AUG-2024
Expiry Date20-AUG-2027

Back to drug list